Skip to main content
OpenTrials

Clinical trial condition

Skin Neoplasms

Explore clinical trials studying Skin Neoplasms. Study availability and eligibility vary by location and protocol.

2,109 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Skin Neoplasms trial results

Active, Not Recruiting

Nivolumab/Ipilimumab Plus Cabozantinib in Patients With Unresectable Advanced Melanoma

NCT04091750

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
  • Medstar Franklin Square Medical Center, Harry and Jeanette Weinberg Cancer Institute Baltimore, Maryland, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details
Active, Not Recruiting

A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)

NCT06346067

Conditions
Advanced or Metastatic NRAS-mutant Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • Mayo Clinic - Arizona Phoenix, Arizona, United States
  • University of California, San Francisco San Francisco, California, United States
  • The Melanoma and Skin Care Institute Englewood, Colorado, United States
  • Mayo Clinic - Florida Jacksonville, Florida, United States
View all 59 locations
View Trial Details
Active, Not Recruiting

A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations

NCT05907304

Conditions
Advanced or Metastatic Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +34 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • Florida Cancer Specialists - St. Petersburg St. Petersburg, Florida, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma

NCT00003641

Conditions
Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States
View all 533 locations
View Trial Details
Active, Not Recruiting

Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete Resection

NCT04666272

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Novartis Investigative Site Fuzhou, Fujian, China
  • Novartis Investigative Site Zhengzhou, Henan, China
  • Novartis Investigative Site Wuhan, Hubei, China
  • Novartis Investigative Site Changsha, Hunan, China
View Trial Details

Related conditions